Pushing Spatiotemporal Limits for 4D Flow MRI and Dynamic MRA in the Brain at Ultra-High Field
1 other identifier
observational
90
1 country
1
Brief Summary
This study aims at investigating the blood hemodynamics with high spatiotemporal resolution in patients with brain aneurysms and AVMs as well as in healthy controls. Parameters such as peak blood velocity, wall shear stress and other derived parameters will be obtained from 4D flow MRI data acquired at ultra-high field strength (7 Tesla).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2015
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 13, 2015
CompletedFirst Posted
Study publicly available on registry
October 15, 2015
CompletedStudy Start
First participant enrolled
November 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2019
CompletedOctober 30, 2019
October 1, 2019
3.8 years
October 13, 2015
October 28, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Brain Flow Dynamics
Altered brain flow hemodynamics in patients with aneurysms and AVMs compared to normal subjects
2 years
Study Arms (2)
Healthy subjects
Subjects with no contraindications to magnetic resonance imaging will undergo 4D flow MRI scanning. 7 Tesla MRI
Patients
Patients with an unruptured brain aneurysm or an unruptured arteriovenous malformation (AVM) with no contraindications to magnetic resonance imaging will undergo 4D flow MRI scanning 7 Tesla MRI
Interventions
Eligibility Criteria
Patients, age 18-75 years; * Patients with previously un-ruptured AVMs, who have had a catheter-guided DSA for evaluation of the AVM; any Spetzler-Martin grade; patients with one or more un-ruptured AVMs regardless of symptoms * Patients with non-symptomatic patients; one or more un-ruptured conservatively managed aneurysms, all aneurysm sizes and shapes (fusiform, saccular, sessile). Subjects: \- healthy subjects between 18 and 75 years.
You may qualify if:
- Subjects / Patients between 18 and 75
You may not qualify if:
- Any kind of ferromagnetic implants.
- MR-unsafe non-ferromagnetic implants.
- Cardiac pacemakers.
- A history of shrapnel or shot gun injury.
- A body mass index \> 40.
- Severe claustrophobia.
- Tattoos in the head/neck area or permanent makeup.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Minnesota Medical Center
Minneapolis, Minnesota, 55414, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bharathi Jagadeesan, MD
University of Minnesota
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 13, 2015
First Posted
October 15, 2015
Study Start
November 1, 2015
Primary Completion
September 1, 2019
Study Completion
September 1, 2019
Last Updated
October 30, 2019
Record last verified: 2019-10